IL245352A - Oral pharmaceutical composition comprising parathyroid hormome or a fragment thereof, protease inhibitor and a salt of nac or nad - Google Patents

Oral pharmaceutical composition comprising parathyroid hormome or a fragment thereof, protease inhibitor and a salt of nac or nad

Info

Publication number
IL245352A
IL245352A IL245352A IL24535216A IL245352A IL 245352 A IL245352 A IL 245352A IL 245352 A IL245352 A IL 245352A IL 24535216 A IL24535216 A IL 24535216A IL 245352 A IL245352 A IL 245352A
Authority
IL
Israel
Prior art keywords
hormome
nac
nad
parathyroid
fragment
Prior art date
Application number
IL245352A
Other languages
Hebrew (he)
Other versions
IL245352A0 (en
Inventor
Kidron Miriam
Arbit Ehud
Original Assignee
Kidron Miriam
Arbit Ehud
Entera Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2009/000786 external-priority patent/WO2010020978A1/en
Application filed by Kidron Miriam, Arbit Ehud, Entera Bio Ltd filed Critical Kidron Miriam
Priority to IL245352A priority Critical patent/IL245352A/en
Publication of IL245352A0 publication Critical patent/IL245352A0/en
Publication of IL245352A publication Critical patent/IL245352A/en

Links

IL245352A 2008-08-18 2016-05-01 Oral pharmaceutical composition comprising parathyroid hormome or a fragment thereof, protease inhibitor and a salt of nac or nad IL245352A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL245352A IL245352A (en) 2008-08-18 2016-05-01 Oral pharmaceutical composition comprising parathyroid hormome or a fragment thereof, protease inhibitor and a salt of nac or nad

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8981208P 2008-08-18 2008-08-18
PCT/IL2009/000786 WO2010020978A1 (en) 2008-08-18 2009-08-11 Methods and compositions for oral administration of proteins
IL245352A IL245352A (en) 2008-08-18 2016-05-01 Oral pharmaceutical composition comprising parathyroid hormome or a fragment thereof, protease inhibitor and a salt of nac or nad

Publications (2)

Publication Number Publication Date
IL245352A0 IL245352A0 (en) 2016-06-30
IL245352A true IL245352A (en) 2017-12-31

Family

ID=56241736

Family Applications (1)

Application Number Title Priority Date Filing Date
IL245352A IL245352A (en) 2008-08-18 2016-05-01 Oral pharmaceutical composition comprising parathyroid hormome or a fragment thereof, protease inhibitor and a salt of nac or nad

Country Status (1)

Country Link
IL (1) IL245352A (en)

Also Published As

Publication number Publication date
IL245352A0 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
NO2018019I2 (en) Ertugliflozin, optionally as a crystal form, especially as a co-crystal with L-pyroglutamic acid, and especially as Ertugliflozin L-pyroglutamic acid
HRP20181971T1 (en) ORAL DOSAGE FORMS CONTAINING ANTI-AGGREGATION AGENT AND ACID INHIBITOR
IL210804A0 (en) Deacetylase inhibitors and uses thereof
IL197752A0 (en) Hdac inhibitors
BRPI0905952A2 (en) Compound and salts thereof and pharmaceutical composition
IL210843A0 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
IL204442A (en) F1f0-atpase inhibitors, pharmaceutical compositions comprising them and use thereof
ATE538092T1 (en) ASPARAGIC ACID PROTEASE INHIBITORS
DK2032535T3 (en) Spiro-cyclic nitriles as protease inhibitors
DK2350026T3 (en) SULFOXIMIN-SUBSTITUTED ANILINOPYRIMIDE INGREDIENTS AS CDK INHIBITORS, PREPARATION AND USE THEREOF AS A MEDICINE
DK200900115U1 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
PL2688572T3 (en) A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof.
IL220586A (en) Carboxamide compound, pharmaceutical composition comprising same and use thereof
EP2358692A4 (en) Cysteine protease inhibitors
IL197965A0 (en) Di-fluoro containing compounds as cysteine protease inhibitors
BRPI0923763A2 (en) compound, use of a compound and pharmaceutical composition
PL1896399T3 (en) Biphenyl and naphthyl-phenyl hydroxamic acid derivatives
GB0624084D0 (en) Ramipril amino acid salts
IL245352A (en) Oral pharmaceutical composition comprising parathyroid hormome or a fragment thereof, protease inhibitor and a salt of nac or nad
GB0624187D0 (en) HDAC inhibitors
ZA200908771B (en) Cysteine protease inhibitors
IL210842A (en) Single, solid composition comprising a protein, a protease inhibitor and a salt of nac or nad and uses thereof for oral administration of the protein
EP2262370A4 (en) Di-fluoro containing compounds as cysteine protease inhibitors
ZA200810270B (en) Segmented pharmaceutical dosage forms
TWI316060B (en) Neuraminidase inhibitor

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed